Suppr超能文献

心外膜射频消融抑制 Brugada 综合征实验模型心律失常发生的机制。

Mechanisms Underlying Epicardial Radiofrequency Ablation to Suppress Arrhythmogenesis in Experimental Models of Brugada Syndrome.

机构信息

Department of Pharmacology and Pharmacotherapy, University of Szeged Faculty of Medicine, Szeged, Hungary.

Masonic Medical Research Laboratory, Utica, New York.

出版信息

JACC Clin Electrophysiol. 2017 Apr;3(4):353-363. doi: 10.1016/j.jacep.2016.10.011. Epub 2016 Dec 21.

Abstract

OBJECTIVES

This study sought to test the hypothesis that elimination of sites of abnormal repolarization, via epicardial RFA, suppresses the electrocardiographic and arrhythmic manifestations of BrS.

BACKGROUND

Brugada syndrome (BrS) is associated with ventricular tachycardia and ventricular fibrillation leading to sudden cardiac death. Nademanee et al. reported that radiofrequency ablation (RFA) of right ventricular outflow tract epicardium significantly reduced the electrocardiogram and arrhythmic manifestations of BrS. These authors concluded that low-voltage fractionated electrogram activity and late potentials are caused by conduction delay within the right ventricular outflow tract and that the ameliorative effect of RFA is caused by elimination of this substrate. Szel et al. recently demonstrated that the abnormal electrogram activity is associated with repolarization defects rather than depolarization or conduction defects.

METHODS

Action potentials (AP), electrograms, and pseudoelectrocardiogram were simultaneously recorded from coronary-perfused canine right ventricular wedge preparations. Two pharmacological models were used to mimic BrS genotype: combination of I blocker ajmaline (1 to 10 μM) and I agonist pinacidil (1 to 5 μM); or combination of I agonist NS5806 (4 to 10 μM) and I blocker verapamil (0.5 to 2 μM). After stable induction of abnormal electrograms and arrhythmic activity, the preparation was mapped and epicardial RFA was applied.

RESULTS

Fractionated low-voltage electrical activity was observed in right ventricular epicardium but not endocardium as a consequence of heterogeneities in the appearance of the second upstroke of the epicardial AP. Discrete late potentials developed as a result of delay of the second upstroke of the AP and of concealed phase 2 re-entry. Epicardial RFA of these abnormalities normalized Brugada pattern and abolished arrhythmic activity, regardless of the pharmacological model used.

CONCLUSIONS

Our results suggest that epicardial RFA exerts its ameliorative effect in the setting of BrS by destroying the cells with the most prominent AP notch, thus eliminating sites of abnormal repolarization and the substrate for ventricular tachycardia ventricular fibrillation.

摘要

目的

本研究旨在验证下述假说,即通过心外膜射频消融(RFA)消除异常复极部位可抑制 BrS 的心电图和心律失常表现。

背景

Brugada 综合征(BrS)与室性心动过速和心室颤动相关,可导致心源性猝死。Nademanee 等报道,右心室流出道心外膜射频消融(RFA)可显著减少 BrS 的心电图和心律失常表现。这些作者得出结论,低电压碎裂电图活动和晚电位是由右心室流出道内传导延迟引起的,而 RFA 的改善作用是由消除该基质引起的。Szel 等最近表明,异常电活动与复极缺陷有关,而与去极化或传导缺陷无关。

方法

从冠状灌注犬右心室楔形标本中同时记录动作电位(AP)、电图和假性心电图。使用两种药理学模型模拟 BrS 基因型:I 阻滞剂阿马林(1 至 10 μM)和 I 激动剂匹那地尔(1 至 5 μM)的组合;或 I 激动剂 NS5806(4 至 10 μM)和 I 阻滞剂维拉帕米(0.5 至 2 μM)的组合。在稳定诱导异常电图和心律失常活动后,对标本进行映射并进行心外膜 RFA。

结果

右心室心外膜而非心内膜出现碎裂低电压电活动,这是由于心外膜 AP 的第二个上升支外观存在异质性所致。离散的晚电位是由于 AP 的第二个上升支延迟和隐藏的 2 相折返引起的。无论使用何种药理学模型,这些异常的心外膜 RFA 均使 Brugada 模式正常化并消除心律失常活动。

结论

我们的结果表明,心外膜 RFA 通过破坏具有最明显 AP 切迹的细胞来发挥其改善作用,从而消除异常复极部位和室性心动过速/心室颤动的基质。

相似文献

1
Mechanisms Underlying Epicardial Radiofrequency Ablation to Suppress Arrhythmogenesis in Experimental Models of Brugada Syndrome.
JACC Clin Electrophysiol. 2017 Apr;3(4):353-363. doi: 10.1016/j.jacep.2016.10.011. Epub 2016 Dec 21.
3
Epicardial Substrate as a Target for Radiofrequency Ablation in an Experimental Model of Early Repolarization Syndrome.
Circ Arrhythm Electrophysiol. 2018 Sep;11(9):e006511. doi: 10.1161/CIRCEP.118.006511.
4
Acacetin suppresses the electrocardiographic and arrhythmic manifestations of the J wave syndromes.
PLoS One. 2020 Nov 24;15(11):e0242747. doi: 10.1371/journal.pone.0242747. eCollection 2020.
5
7
Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation.
Circ Arrhythm Electrophysiol. 2015 Dec;8(6):1373-81. doi: 10.1161/CIRCEP.115.003220. Epub 2015 Aug 19.
8
Mechanisms underlying the development of the electrocardiographic and arrhythmic manifestations of early repolarization syndrome.
J Mol Cell Cardiol. 2014 Mar;68:20-8. doi: 10.1016/j.yjmcc.2013.12.012. Epub 2013 Dec 28.
9
Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.
Circ Arrhythm Electrophysiol. 2017 May;10(5):e005053. doi: 10.1161/CIRCEP.117.005053.
10
Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants.
J Cardiovasc Electrophysiol. 2012 Apr;23(4):423-32. doi: 10.1111/j.1540-8167.2011.02196.x. Epub 2011 Oct 28.

引用本文的文献

2
Ventricular arrhythmias induced by phase 2 reentry in a patient with J-wave syndrome.
HeartRhythm Case Rep. 2023 Jun 19;9(9):629-633. doi: 10.1016/j.hrcr.2023.06.008. eCollection 2023 Sep.
3
Dynamics of unipolar J-ST elevation coupled to bipolar delayed potentials on the epicardium in Brugada syndrome: a case report.
Eur Heart J Case Rep. 2023 Aug 3;7(8):ytad377. doi: 10.1093/ehjcr/ytad377. eCollection 2023 Aug.
4
Genetic and Molecular Mechanisms in Brugada Syndrome.
Cells. 2023 Jul 5;12(13):1791. doi: 10.3390/cells12131791.
5
Functional Epicardial Conduction Disturbances Due to a SCN5A Variant Associated With Brugada Syndrome.
JACC Clin Electrophysiol. 2023 Aug;9(8 Pt 1):1248-1261. doi: 10.1016/j.jacep.2023.03.009. Epub 2023 May 24.
6
Subepicardial Cardiomyopathy: A Disease Underlying J-Wave Syndromes and Idiopathic Ventricular Fibrillation.
Circulation. 2023 May 23;147(21):1622-1633. doi: 10.1161/CIRCULATIONAHA.122.061924. Epub 2023 May 22.
7
Antiarrhythmic Effect of Artemisinin in an Ex-vivo Model of Brugada Syndrome Induced by NS5806.
Korean Circ J. 2023 Apr;53(4):239-250. doi: 10.4070/kcj.2022.0312.
9
Brugada Syndrome: Different Experimental Models and the Role of Human Cardiomyocytes From Induced Pluripotent Stem Cells.
J Am Heart Assoc. 2022 Apr 5;11(7):e024410. doi: 10.1161/JAHA.121.024410. Epub 2022 Mar 24.

本文引用的文献

1
Fibrosis, Connexin-43, and Conduction Abnormalities in the Brugada Syndrome.
J Am Coll Cardiol. 2015 Nov 3;66(18):1976-1986. doi: 10.1016/j.jacc.2015.08.862.
2
Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation.
Circ Arrhythm Electrophysiol. 2015 Dec;8(6):1373-81. doi: 10.1161/CIRCEP.115.003220. Epub 2015 Aug 19.
3
J-wave syndromes: Brugada and early repolarization syndromes.
Heart Rhythm. 2015 Aug;12(8):1852-66. doi: 10.1016/j.hrthm.2015.04.014. Epub 2015 Apr 11.
4
Cardiac electrophysiological substrate underlying the ECG phenotype and electrogram abnormalities in Brugada syndrome patients.
Circulation. 2015 Jun 2;131(22):1950-9. doi: 10.1161/CIRCULATIONAHA.114.013698. Epub 2015 Mar 25.
5
Genetically engineered SCN5A mutant pig hearts exhibit conduction defects and arrhythmias.
J Clin Invest. 2015 Jan;125(1):403-12. doi: 10.1172/JCI76919. Epub 2014 Dec 15.
6
Distinctive electrophysiological characteristics of right ventricular out-flow tract cardiomyocytes.
J Cell Mol Med. 2014 Aug;18(8):1540-8. doi: 10.1111/jcmm.12329. Epub 2014 Jun 9.
9
J wave syndromes: molecular and cellular mechanisms.
J Electrocardiol. 2013 Nov-Dec;46(6):510-8. doi: 10.1016/j.jelectrocard.2013.08.006. Epub 2013 Sep 6.
10
Insight into the mechanism of Brugada syndrome: epicardial substrate and modification during ajmaline testing.
Heart Rhythm. 2014 Apr;11(4):732-4. doi: 10.1016/j.hrthm.2013.05.023. Epub 2013 May 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验